These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 19699300
1. LRP1 regulates remodeling of the extracellular matrix by fibroblasts. Gaultier A, Hollister M, Reynolds I, Hsieh EH, Gonias SL. Matrix Biol; 2010 Jan; 29(1):22-30. PubMed ID: 19699300 [Abstract] [Full Text] [Related]
2. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System. Merino P, Diaz A, Jeanneret V, Wu F, Torre E, Cheng L, Yepes M. J Biol Chem; 2017 Feb 17; 292(7):2741-2753. PubMed ID: 27986809 [Abstract] [Full Text] [Related]
3. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain. Diaz A, Merino P, Manrique LG, Ospina JP, Cheng L, Wu F, Jeanneret V, Yepes M. J Neurosci; 2017 Oct 25; 37(43):10310-10322. PubMed ID: 28931568 [Abstract] [Full Text] [Related]
4. Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1). Gonias SL, Gaultier A, Jo M. Curr Pharm Des; 2011 Oct 25; 17(19):1962-9. PubMed ID: 21711236 [Abstract] [Full Text] [Related]
5. The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts. Monaghan E, Gueorguiev V, Wilkins-Port C, McKeown-Longo PJ. J Biol Chem; 2004 Jan 09; 279(2):1400-7. PubMed ID: 14602715 [Abstract] [Full Text] [Related]
6. Membrane type-1 matrix metalloproteinase activity is regulated by the endocytic collagen receptor Endo180. Messaritou G, East L, Roghi C, Isacke CM, Yarwood H. J Cell Sci; 2009 Nov 15; 122(Pt 22):4042-8. PubMed ID: 19861500 [Abstract] [Full Text] [Related]
7. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk. Beloglazova I, Stepanova V, Zubkova E, Dergilev K, Koptelova N, Tyurin-Kuzmin PA, Dyikanov D, Plekhanova O, Cines DB, Mazar AP, Parfyonova Y. Biochim Biophys Acta Mol Cell Res; 2022 Jan 15; 1869(1):119157. PubMed ID: 34619163 [Abstract] [Full Text] [Related]
8. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. Czekay RP, Aertgeerts K, Curriden SA, Loskutoff DJ. J Cell Biol; 2003 Mar 03; 160(5):781-91. PubMed ID: 12615913 [Abstract] [Full Text] [Related]
9. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts. Grove LM, Southern BD, Jin TH, White KE, Paruchuri S, Harel E, Wei Y, Rahaman SO, Gladson CL, Ding Q, Craik CS, Chapman HA, Olman MA. J Biol Chem; 2014 May 02; 289(18):12791-804. PubMed ID: 24644284 [Abstract] [Full Text] [Related]
10. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity. Montgomery N, Hill A, McFarlane S, Neisen J, O'Grady A, Conlon S, Jirstrom K, Kay EW, Waugh DJ. Breast Cancer Res; 2012 May 23; 14(3):R84. PubMed ID: 22621373 [Abstract] [Full Text] [Related]
12. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X. Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513 [Abstract] [Full Text] [Related]
13. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. Zhang G, Cai X, López-Guisa JM, Collins SJ, Eddy AA. J Am Soc Nephrol; 2004 Aug 01; 15(8):2090-102. PubMed ID: 15284295 [Abstract] [Full Text] [Related]
14. Urokinase-type plasminogen activator negatively regulates α-smooth muscle actin expression via Endo180 and the uPA receptor in corneal fibroblasts. Sugioka K, Nishida T, Kodama-Takahashi A, Murakami J, Mano F, Okada K, Fukuda M, Kusaka S. Am J Physiol Cell Physiol; 2022 Jul 01; 323(1):C104-C115. PubMed ID: 35649252 [Abstract] [Full Text] [Related]
16. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS. J Biol Chem; 2005 Oct 28; 280(43):36529-40. PubMed ID: 16127174 [Abstract] [Full Text] [Related]
17. Activated α2-macroglobulin induces Müller glial cell migration by regulating MT1-MMP activity through LRP1. Barcelona PF, Jaldín-Fincati JR, Sánchez MC, Chiabrando GA. FASEB J; 2013 Aug 28; 27(8):3181-97. PubMed ID: 23640058 [Abstract] [Full Text] [Related]
18. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Behrendt N. Biol Chem; 2004 Feb 28; 385(2):103-36. PubMed ID: 15101555 [Abstract] [Full Text] [Related]
19. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand. Gliemann J, Hermey G, Nykjaer A, Petersen CM, Jacobsen C, Andreasen PA. Biochem J; 2004 Jul 01; 381(Pt 1):203-12. PubMed ID: 15053742 [Abstract] [Full Text] [Related]
20. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. Weaver AM, Hussaini IM, Mazar A, Henkin J, Gonias SL. J Biol Chem; 1997 May 30; 272(22):14372-9. PubMed ID: 9162074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]